Search for stocks /

PNB Gilts Ltd Q1 FY26 + G-Secs, 435% PAT Growth, and 31% CAR Flex – A Bond Bazaar Detective Story


1. At a Glance

PNB Gilts, the RBI’s favourite sidekick in government bond auctions, has delivered a 199% YoY jump in Q1 PAT. A business where 99% of revenue is just “interest income” somehow posted a quarterly profit margin of 28%. With a P/E of 5.5, a Capital Adequacy Ratio (CAR) of 31.8%, and a balance sheet carrying ₹22,384 Cr of borrowings, the stock looks like a government-backed FD that went rogue and listed on NSE.


2. Introduction

Welcome to the curious case of PNB Gilts. Think of them as India’s official bond bazaar detective—they show up whenever the government needs money, underwrite debt, and then trade those very bonds in the secondary market.

The company exists in a boring corner of finance: government securities, T-bills, state loans, corporate bonds. Basically, if you can’t touch it, smell it, or use it in your bathroom, PNB Gilts probably trades it. It’s the kind of business that’s essential but invisible, like the WiFi router in your house.

And yet, beneath this dull exterior lies a stock that delivered 435% profit growth TTM, a CAR twice the RBI minimum, and a promoter (PNB) sitting with a 74% stake. The catch? ROA is just 0.94%, interest coverage is thin at 1.35x, and dividend payouts are stingy at 11%.

So the question is—do you treat PNB Gilts as a cash cow or as that distant cousin who always brags about “government connections” but never pays for dinner?


3. Business Model – WTF Do They Even Do?

PNB Gilts’ job description is fairly simple but wrapped in finance jargon:

  • Primary Dealer Role: Underwrite and distribute central government bonds. They’re basically the middlemen who make sure the government’s borrowing program runs smoothly.
  • Fixed Income Trading: Invest and trade in G-Secs, state loans, PSU bonds, corporate bonds, T-bills, CPs, CDs. In short, if it has a coupon, they’ll clip it.
  • Derivatives: Play around with interest rate swaps—hedging when rates go up, praying when they don’t.
  • Fee Business: Barely 1% of revenue. Advisory services for G-Sec portfolios, gilt accounts, inter-corporate deposits. Let’s just call this “pocket money.”
  • Equity & FX Forays: Management claims they’ll diversify into equity, FX, and other fee-generating segments. Translation: “We’re bored of gilts; let’s try trading like the cool kids.”

Detective note: 99% of revenue is still interest income. Diversification is more press release than profit stream.


4. Financials Overview

MetricLatest Qtr (Q1 FY26)YoY Qtr (Q1 FY25)Prev Qtr (Q4 FY25)YoY %QoQ %
Revenue (₹ Cr)56344041927.9%34.4%
EBITDA (₹ Cr)53842640726.4%32.2%
PAT (₹ Cr)1605375199%113%
EPS (₹)8.93.04.2199%112%

Commentary:
Margins at 95% OPM? This is less business and more arbitrage machine. PAT has doubled QoQ, thanks to bond market movements. But remember, trading gains = fickle friends.


5. Valuation Discussion – Fair Value Range

Method 1: P/E Method

  • EPS = ₹18.9
  • Industry P/E = 33
  • Fair Value Range = ₹100 – ₹600 (yes, wide, because bond dealers swing).

Method 2: P/B Method

  • Book Value = ₹85.8
  • P/B historical range: 1x–2x
  • Fair Value Range = ₹85 – ₹170.

Method 3: DCF (Notional)

  • Assume profits grow at 8% CAGR (conservative, rate-cycle sensitive).
  • Intrinsic Value Range = ₹120 – ₹180.

Conclusion:
Fair Value Range = ₹100 – ₹180.
CMP = ₹104 → stock is at the floor of the fair zone.

Disclaimer: This fair value range is for educational purposes only and is not investment advice.


6. What’s Cooking – News, Triggers, Drama

  • Dividend ₹1/share approved at AGM Sep 2025. Don’t get excited—it’s barely 1% yield.
  • New MD & CEO appointed for 3 years (Pareed Sunil). Fresh detective in charge.
  • CRISIL reaffirmed A1+ rating on ₹1,000 Cr CP program. Basically, “short-term debt safe.”
  • CAR at 31.8% vs RBI requirement of 15% → buffer thicker than a railway platform chai.
  • Parent PNB still holds 74.1% stake, meaning strong bank backing.

Question: Would you trust a company that lives and dies by RBI rate moves more than a pharma company selling paracetamol?


7. Balance Sheet

YearAssets (₹ Cr)Liabilities (₹ Cr)Net Worth (₹ Cr)Borrowings (₹ Cr)
202112,1409,0041,3169,864
202216,75015,5031,42714,531
202321,49720,4171,26019,243
202424,54023,4581,13522,403
202524,70223,1571,54522,384

Commentary: Balance sheet looks like a giant trading book—₹22,000+ Cr of borrowings funding

Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!